The DOI matches its OpenAlex record; 43 of the 43 references it cites were found in a registry or an index.
Convalescent plasma: new evidence for an old therapeutic tool?
Open accessAbstract
Passive immunisation for the prevention and treatment of human infectious diseases can be traced back to the 20(th) century. The recent Ebola virus outbreak in West Africa has turned the spotlight onto the possible use of convalescent whole blood and convalescent plasma in the treatment of infectious diseases because they are the only therapeutic strategy available in some cases, given the unavailability of vaccines, drugs or other specific treatments. Convalescent blood products could be a valid option in the treatment/prophylaxis of several infectious diseases both in association with other drugs/preventive measures and as the only therapy when a specific treatment is not available. However, there are still some issues to consider in determining the advisability of implementing a large-scale convalescent plasma transfusion programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P., Khaw, F.-M., Lim, W. S., Makki, S., Rooney, K. D., Convalescent Plasma Study Group, Nguyen-Van-Tam, J. S., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu396 · Cited by 983
Guzman, M. G., Alvarez, M., & Halstead, S. B. (2013) · Archives of Virology · doi:10.1007/s00705-013-1645-3 · Cited by 738
Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?
Luke, T. C., Kilbane, E. M., Jackson, J. L., & Hoffman, S. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00139 · Cited by 636
Ebola haemorrhagic fever in Zaire
Otatume, S. (1996) · Journal of African Studies · doi:10.11619/africa1964.1996.49_95 · Cited by 474
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Wang, S.-F., Tseng, S.-P., Yen, C.-H., Yang, J.-Y., Tsao, C.-H., Shen, C.-W., Chen, K.-H., Liu, F.-T., Liu, W.-T., Chen, Y.-M. A., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.090 · Cited by 421
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients
Mupapa, K., Massamba, M., Kibadi, K., Kuvula, K., Bwaka, A., Kipasa, M., Colebunders, R., Muyembe‐Tamfum, J. J., & the International Scientific and Technical Committee (1999) · The Journal of Infectious Diseases · doi:10.1086/514298 · Cited by 420
Treatment with Convalescent Plasma for Influenza A (H5N1) Infection
Zhou, B., Zhong, N., & Guan, Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070359 · Cited by 406
Passive immunity in prevention and treatment of infectious diseases
Keller, M. A., & Stiehm, E. R. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.602 · Cited by 388
Olinger, G. G., Pettitt, J., Kim, D., Working, C., Bohorov, O., Bratcher, B., Hiatt, E., Hume, S. D., Johnson, A. K., Morton, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213709109 · Cited by 366
Dengue Antibody-Dependent Enhancement: Knowns and Unknowns
Halstead, S. B. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.aid-0022-2014 · Cited by 336
Maiztegui, J., Fernandez, N., & De Damilano, A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92335-3 · Cited by 332
Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies
Qiu, X., Audet, J., Wong, G., Pillet, S., Bello, A., Cabral, T., Strong, J. E., Plummer, F., Corbett, C. R., Alimonti, J. B., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003876 · Cited by 315
Antibody-Dependent Enhancement of Virus Infection and Disease
Tirado, S. M. C., & Yoon, K.-J. (2003) · Viral Immunology · doi:10.1089/088282403763635465 · Cited by 313
The WHO MERS-CoV Research Group (2013) · PLoS Currents · doi:10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8 · Cited by 309
Human Ebola virus infection results in substantial immune activation
McElroy, A. K., Akondy, R. S., Davis, C. W., Ellebedy, A. H., Mehta, A. K., Kraft, C. S., Lyon, G. M., Ribner, B. S., Varkey, J., Sidney, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502619112 · Cited by 306
Jahrling, P. B., Geisbert, T. W., Geisbert, J. B., Swearengen, J. R., Bray, M., Jaax, N. K., Huggins, J. W., LeDuc, J. W., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514310 · Cited by 269
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
Dye, J. M., Herbert, A. S., Kuehne, A. I., Barth, J. F., Muhammad, M. A., Zak, S. E., Ortiz, R. A., Prugar, L. I., & Pratt, W. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200409109 · Cited by 268
Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
Oswald, W. B., Geisbert, T. W., Davis, K. J., Geisbert, J. B., Sullivan, N. J., Jahrling, P. B., Parren, P. W. H. I., & Burton, D. R. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030009 · Cited by 230
Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza
Simmons, C. P., Bernasconi, N. L., Suguitan, A. L., Mills, K., Ward, J. M., Chau, N. V. V., Hien, T. T., Sallusto, F., Ha, D. Q., Farrar, J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040178 · Cited by 208
Parren, P. W. H. I., Geisbert, T. W., Maruyama, T., Jahrling, P. B., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6408-6412.2002 · Cited by 204
Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection
Boonnak, K., Slike, B. M., Burgess, T. H., Mason, R. M., Wu, S.-J., Sun, P., Porter, K., Rudiman, I. F., Yuwono, D., Puthavathana, P., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02484-07 · Cited by 191
Enria, D., Fernandez, N., Briggiler, A., Levis, S., & Maiztegui, J. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90299-x · Cited by 184
Olsen, C. W., Corapi, W. V., Ngichabe, C. K., Baines, J. D., & Scott, F. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.956-965.1992 · Cited by 179
Jahrling, P. B., Geisbert, J., Swearengen, J. R., Jaax, G. P., Lewis, T., Huggins, J. W., Schmidt, J. J., LeDuc, J. W., & Peters, C. J. (1996) · Imported Virus Infections · doi:10.1007/978-3-7091-7482-1_12 · Cited by 175
Antiviral treatment of argentine hemorrhagic fever
Enria, D. A., & Maiztegui, J. I. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90030-2 · Cited by 161
How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections
Ubol, S., & Halstead, S. B. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00316-10 · Cited by 151
Hark back: Passive immunotherapy for influenza and other serious infections
Luke, T. C., Casadevall, A., Watowich, S. J., Hoffman, S. L., Beigel, J. H., & Burgess, T. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181d44c1e · Cited by 150
Prince, G. A., Hemming, V. G., Horswood, R. L., Baron, P. A., & Chanock, R. M. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.1851-1854.1987 · Cited by 146
Treatment of severe acute respiratory syndrome with convalescent plasma.
Wong, V. W., Dai, D., Wu, A. K. L., & Sung, J. J. �. (2003) · PubMed · Cited by 142
Preparation and Use of Hyperimmune Serum for Prophylaxis and Therapy of Ebola Virus Infections
Зубавичене, Н. М., Sergeyev, N. N., Чепурнов, А. А., & Sv, N. (1999) · The Journal of Infectious Diseases · doi:10.1086/514294 · Cited by 130
Post-exposure passive immunisation for preventing measles
Young, M. K., Nimmo, G. R., Cripps, A. W., & Jones, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010056.pub2 · Cited by 78
Use of Intravenous Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases
Hemming, V. G. (2001) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.5.859-863.2001 · Cited by 77
Ebola virus convalescent blood products: Where we are now and where we may need to go
Burnouf, T., & Seghatchian, J. (2014) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2014.10.003 · Cited by 76
Successful treatment of avian influenza with convalescent plasma.
Kong, L.-B., & Zhou, B. P. (2006) · PubMed · Cited by 73
Dodd, R. Y. (2012) · British Journal of Haematology · doi:10.1111/bjh.12031 · Cited by 68
Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product?
Leider, J. P., Brunker, P. A. R., & Ness, P. M. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02590.x · Cited by 54
Adjunctive therapies and immunomodulating agents for severe influenza
Hui, D. S. C., & Lee, N. L. S. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12171 · Cited by 40
Ebola virus disease, transmission risk to laboratory personnel, and pretransfusion testing
Katz, L. M., & Tobian, A. A. R. (2014) · Transfusion · doi:10.1111/trf.12913 · Cited by 38
Role of plant expression systems in antibody production for passive immunization
Virdi, V., & Depicker, A. (2013) · The International Journal of Developmental Biology · doi:10.1387/ijdb.130266ad · Cited by 36
Convalescent whole blood, plasma and serum in the prophylaxis of measles
Zingher, A., & Mortimer, P. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.480 · Cited by 34
Lai, K. Y., Ng, W. Y. G., & Cheng, F. (2014) · Infectious Diseases of Poverty · doi:10.1186/2049-9957-3-43 · Cited by 33
Evaluating Large-scale Blood Transfusion Therapy for the Current Ebola Epidemic in Liberia
Gutfraind, A., & Ancel, L. W. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv042 · Cited by 22
A study in scarlet-convalescent plasma for severe influenza*
Beigel, J. H., & Luke, T. C. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31823d77c3 · Cited by 12
Cited by
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004168117 · Cited by 1,960
Potential interventions for novel coronavirus in China: A systematic review
Zhang, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25707 · Cited by 1,348
Convalescent plasma in Covid-19: Possible mechanisms of action
Rojas, M., Rodríguez, Y., Monsalve, D. M., Acosta-Ampudia, Y., Camacho, B., Gallo, J. E., Rojas-Villarraga, A., Ramírez-Santana, C., Díaz-Coronado, J. C., Manrique, R., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102554 · Cited by 491
Chan, K. W., Wong, V. T., & Tang, S. C. W. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500378 · Cited by 398
Ahn, J. Y., Sohn, Y., Lee, S. H., Cho, Y., Hyun, J. H., Baek, Y. J., Jeong, S. J., Kim, J. H., Ku, N. S., Yeom, J.-S., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e149 · Cited by 352
Metadata
- Authors
- Marano, G., Vaglio, S., Pupella, S., Facco, G., Catalano, L., Liumbruno, G. M., & Grazzini, G.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2016-03-01
- Volume
- 14
- Issue
- 2
- Pages
- 152-7
- OpenAlex
- W2412511529
- Cited by
- 322
- References
- 43
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.